hella, I have a question about Cotara that's been bothering me. The person who told me about PPHM also, as true for you, became interested in PPHM because of Cotara and a personal connection to brain cancer.
If Cotara can result in some people who know that they will die quickly to live even just a few months longer, as so far it appears Cotara can, why has the company taken so long to get where it is? Why five years for the phase II, in particular?
I don't have a problem with the delays pre- stage II, because early R&D takes the time it takes, and I don't have a problem with the company waiting from December 2012 in order to raise cash from a bavi or a direct Cotara partner, but those five years seem interminable to me. What happened that caused Cotara to take so painfully long in their phase II?
News 
Market Data 
Discover 
AI
